Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. | Curr Med Res Opin;13(9): 517-27, 1997. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.

Pacetti, P; Garau, D; Caramatti, C; Mangoni, L; Zamboni, V; Canova, N; Rizzoli, V.

Affiliation

Pacetti P; Department of Haematology, University of Parma, Italy.

Curr Med Res Opin ; 13(9): 517-27, 1997.

Article in En | MEDLINE | ID: mdl-9169254

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / Immunoglobulins, Intravenous Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Curr Med Res Opin Year: 1997 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / Immunoglobulins, Intravenous Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Curr Med Res Opin Year: 1997 Document type: Article Affiliation country: